34626-06-7 Usage
Uses
Used in Pharmaceutical Industry:
2-(Pyridin-4-yl)-1H-imidazole-5-carboxylic acid is used as a key intermediate in the synthesis of pharmaceuticals for its potential role in developing anti-cancer and anti-fungal drugs. Its unique structure allows for the creation of new drug candidates that can target specific biological pathways or receptors, offering novel treatment options for various diseases.
Used in Organic Synthesis:
In the field of organic synthesis, 2-(Pyridin-4-yl)-1H-imidazole-5-carboxylic acid is utilized as a building block for the creation of other complex organic compounds. Its versatile chemical properties enable it to be a component in the synthesis of a wide range of molecules, including those with potential applications in materials science, agrochemicals, and other specialty chemical markets.
Used in Scientific Research:
2-(Pyridin-4-yl)-1H-imidazole-5-carboxylic acid is employed as a research tool in various scientific studies. Its unique structure and properties make it an interesting subject for investigations into new chemical reactions, mechanisms, and the development of new methodologies in synthetic chemistry. Additionally, its potential biological activities make it a candidate for studies in medicinal chemistry and drug discovery.
Check Digit Verification of cas no
The CAS Registry Mumber 34626-06-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,4,6,2 and 6 respectively; the second part has 2 digits, 0 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 34626-06:
(7*3)+(6*4)+(5*6)+(4*2)+(3*6)+(2*0)+(1*6)=107
107 % 10 = 7
So 34626-06-7 is a valid CAS Registry Number.
34626-06-7Relevant articles and documents
4-Trifluoromethylimidazoles and 5-(4-pyridyl)-1,2,4-triazoles, new classes of xanthine oxidase inhibitors.
Baldwin et al.
, p. 895,896 (2007/10/04)
The syntheses of a number of 2-substituted 4-trifluoromethylimidazoles and 3-substituted 5-(4-pyridyl)-1,2,4-triazoles are described. The trifluoromethylimidazoles were prepared from 3,3-dibromo-1,1,1-trifluoroacetone after hydrolysis with aqueous sodium acetate solution and condensation with an aldehyde in the presence of ammonia. Basic hydrolysis of the trifluoromethyl group was found to provide a facile method for the synthesis of imidazole-4-carboxylic acids. In the imidazole series a 2-aryl substituent and a free imino group were required for xanthine oxidase inhibitory activity. The triazoles were obtained through the reaction of an aroylhydrazine and an imino ether followed by thermal ring closure of the intermediate acylamidrazone. As in the imidazole series, a free imino group is an absolute requirement for in vitro activity. Additional structure-activity relationships of these compounds are presented.
